P-EP005. Recurrent focal seizure in subdural hemorrhage patient after anticoagulant oral therapy: Case report

2021 ◽  
Vol 132 (8) ◽  
pp. e81
Author(s):  
Atitya Fithri Khairani ◽  
Paryono ◽  
Distya Hening ◽  
Siti Zulaikhah
2021 ◽  
Vol 202 ◽  
pp. 106505
Author(s):  
Massimiliano Minardi ◽  
Giovanni Giulio Vercelli ◽  
Marco Mammi ◽  
Alessandro Fiumefreddo ◽  
Diego Garbossa

1996 ◽  
Vol 19 (2) ◽  
pp. 113-117 ◽  
Author(s):  
Gabriele Wurm ◽  
Peter Pogady ◽  
Karin Lungenschmid ◽  
Johannes Fischer

2009 ◽  
Vol 56 (1) ◽  
pp. 116
Author(s):  
Seung-gyu Jeon ◽  
Byung Hoon Yoo ◽  
Yun-Hee Lim ◽  
Sangseok Lee ◽  
Ki Hyuk Hong

2018 ◽  
Vol 2018 ◽  
pp. 1-3
Author(s):  
Rohan Bhimani ◽  
Fardeen Bhimani ◽  
Preeti Singh

Introduction. Intracranial hypotension may occur when CSF leaks from the subarachnoid space. Formation of intracranial, subdural, and subarachnoid hemorrhage has been observed after significant CSF leak as seen in lumbar puncture or ventricular shunt placement. However, very few cases, referring to these remote complications following spine surgery, have been described in literature. We present a case of a 10-year-old male child operated for idiopathic scoliosis with low-lying conus medullaris who postoperatively developed subdural hemorrhage. Case Report. A case of a 10-year-old male operated for idiopathic scoliosis with low-lying conus medullaris is presented. To correct this, detethering was done at the L3 level, laminectomy was done from L2 to L3 with pedicular screw fixation from T3 to L2, and bone grafting with right costoplasty was done from the 3rd to the 6th ribs. On the 5th day postoperatively, the patient developed convulsions and drowsiness and recovered subsequently by postoperative day 7. Conclusion. We report a rare case of an acute intracranial subdural hemorrhage caused by intracranial hypotension following scoliosis and detethering of cord surgery. This report highlights the potential morbidity associated with CSF leak occurring after this surgery.


2012 ◽  
Vol 6 (1) ◽  
Author(s):  
Tetsuo Hagino ◽  
Satoshi Ochiai ◽  
Yoshiyuki Watanabe ◽  
Shinya Senga ◽  
Masanori Saito ◽  
...  

2021 ◽  
Vol 12 ◽  
Author(s):  
Giorgia Sforza ◽  
Claudia Ruscitto ◽  
Romina Moavero ◽  
Fabiana Ursitti ◽  
Michela Ada Noris Ferilli ◽  
...  

We report three cases of pediatric patients suffering from migraine aura triggered seizures. This entity, also called migralepsy, still does not have a unique definition today. Migraine and epilepsy are both episodic neurological disorders with periods of interictal well-being; this is indicative of similar pathophysiological mechanisms, such as increased neuronal excitation and ion channel dysfunction. The purpose of this paper is to discuss the clinical and instrumental features of migralepsy through the description of three clinical cases in which the symptoms of the usual migraine aura developed into a generalized tonic–clonic or focal seizure.


2021 ◽  
Author(s):  
Chun Seng Phua ◽  
Shalini Bhaskar ◽  
Azman Ali Raymond

Abstract IntroductionAs more novel COVID-19 vaccines are being rolled out in a frantic pace globally, any complication that might be related to COVID-19 vaccines should be highlighted, especially since COVID-19 vaccines are relatively new, and side effects may yet to be fully elucidated. We report a case of a healthy 18-year-old male who presented with new onset focal seizures 5 days after receiving 1st dose of Oxford/AstraZeneca COVID-19 vaccine. Case PresentationThe patient was treated with intravenous phenytoin and oral levetiracetam 250mg twice daily with no further events. There was no documented fever. CT venogram and EEG were unremarkable. MRI brain revealed generalised atrophy including mild bilateral hippocampal atrophy with no evidence of sclerosis. There was no predilection for seizures identified from the patient’s history. The patient was discharged the following day on levetiracetam and advised to proceed with the 2nd dose of Oxford/AstraZeneca COVID-19 vaccination in 3 months’ time.ConclusionSeizures following COVID-19 vaccination have only been reported in a handful of cases. COVID-19 vaccination could lower seizure threshold, or unmask an underlying predisposition for epilepsy. As most COVID-19 vaccines worldwide are given in 2 doses, clinicians should consider maintaining patients on anti-seizure drugs if vaccination was thought to be a provoking factor.


Sign in / Sign up

Export Citation Format

Share Document